Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Osteosarcoma
ADR ID BADD_A03224
ADR Hierarchy
15      Musculoskeletal and connective tissue disorders
15.09      Musculoskeletal and connective tissue neoplasms
15.09.03      Malignant musculoskeletal and connective tissue neoplasms
15.09.03.010      Osteosarcoma
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.29      Skeletal neoplasms malignant and unspecified
16.29.03      Bone sarcomas
16.29.03.002      Osteosarcoma
Description A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed) [MeSH]
MedDRA Code 10031291
MeSH ID D012516
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Anaplastic osteosarcoma | Anaplastic osteosarcoma localized | Chondrosarcomatous osteosarcoma | Chondrosarcomatous osteosarcoma localized | Mixed osteosarcoma | Mixed osteosarcoma localized | Osteoblastic osteosarcoma | Osteoblastic osteosarcoma localized | Osteogenic sarcoma | Osteogenic sarcoma localized | Osteosarcoma | Osteosarcoma localised | Osteosarcoma NOS | Osteosarcoma stage unspecified | Sarcoma osteogenic | Telangiectatic osteosarcoma | Telangiectatic osteosarcoma localized | Anaplastic osteosarcoma localised | Osteoblastic osteosarcoma localised | Osteogenic sarcoma localised | Telangiectatic osteosarcoma localised | Osteosarcomas | Osteosarcoma Tumor | Osteosarcoma Tumors | Tumor, Osteosarcoma | Tumors, Osteosarcoma | Sarcoma, Osteogenic | Osteogenic Sarcomas | Sarcomas, Osteogenic | Osteogenic Sarcoma
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01673Parathyroid hormone--
BADD_D01687Pazopanib0.000168%
BADD_D01901Radium--
BADD_D01902Radium chloride ra-223--
BADD_D02058Sorafenib0.000112%
BADD_D02106Tadalafil0.000293%
BADD_D02166Teriparatide--
The 1th Page    1    Total 1 Pages